0 Days
0 Hours
0 Mins
0 Secs
Cagrilintide 5mg+Semaglutide 5mg
For Research Use Only
This combination (Cagrilintide 5mg + Semaglutide 5mg) is an experimental treatment for weight management and type 2 diabetes. It functions by combining an amylin analog (Cagrilintide) with a GLP-1 receptor agonist (Semaglutide) to enhance appetite control and improve glycemic outcomes.
$186.00
In stock
